04-30-2020, 12:42 PM
From Sky's Link:
So a person uneducated of the medical profession would conclude that the increased potentiality of death involves the
intensive care units. Since the trial information doesn't relate any dosage changes of the chemical-combination and the
exact amounts were administered, what other variables could be at play?
From the findings:
"Poor clinical outcome was significantly associated to older age (OR 1.11), initial higher severity (OR 10.05) and
low hydroxychloroquine serum concentration...
...Both poor clinical and virological outcomes were associated to the use of selective beta-blocking agents and
angiotensin II receptor blockers (P<0.05).
Mortality was significantly lower in patients who had received > 3 days of HCQ-AZ than in patients treated with
other regimens both at IHU and in all Marseille public hospitals..."
The intensive care units are providing the wrong care? Trump was correct? They're killing-off the old bastards in hospital?!
This stuff should be rolled-out as -at least, a positive arrow in the medical world's quiver.
Quote:'The new study, of which the abstract was released today, was performed at IHU Méditerranée Infection, Marseille, FranceLink:
A cohort of 1061 COVID-19 patients, treated for at least 3 days with the Hydroxychloroquine-Azithromycin (HCQ-AZ)
combination and a follow-up of at least 9 days was investigated.
Key findings are:
No cardiac toxicity was observed.
A good clinical outcome and virological cure was obtained in 973 patients within 10 days (91.7%).
A poor outcome was observed for 46 patients (4.3%); 10 were transferred to intensive care units, 5 patients died (0.47%)
(74-95 years old) and 31 required 10 days of hospitalization or more.
The authors conclude that:
“The HCQ-AZ combination, when started immediately after diagnosis, is a safe and efficient treatment for COVID-19, with a
mortality rate of 0.5%, in elderly patients. It avoids worsening and clears virus persistence and contagiosity in most cases.”...'
So a person uneducated of the medical profession would conclude that the increased potentiality of death involves the
intensive care units. Since the trial information doesn't relate any dosage changes of the chemical-combination and the
exact amounts were administered, what other variables could be at play?
From the findings:
"Poor clinical outcome was significantly associated to older age (OR 1.11), initial higher severity (OR 10.05) and
low hydroxychloroquine serum concentration...
...Both poor clinical and virological outcomes were associated to the use of selective beta-blocking agents and
angiotensin II receptor blockers (P<0.05).
Mortality was significantly lower in patients who had received > 3 days of HCQ-AZ than in patients treated with
other regimens both at IHU and in all Marseille public hospitals..."
The intensive care units are providing the wrong care? Trump was correct? They're killing-off the old bastards in hospital?!
This stuff should be rolled-out as -at least, a positive arrow in the medical world's quiver.
Edith Head Gives Good Wardrobe.